Toremifene Fareston Doses, Administration & Side Effects

This medicine is available only with your doctor’s prescription. Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. Toremifene is a member of the hormones/antineoplastics drug class and is commonly used for Breast Cancer, and Breast Cancer – Metastatic. Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Laboratory Tests

• Before taking toremifene, tell your healthcare provider about any prescription or over-the-counter (OTC) medicines, vitamins/minerals, herbal products, and other supplements you are using.
• Combination therapy of paclitaxel and toremifene was safe and well tolerated with minimal toxicity.
• Use an effective form of birth control to keep from getting pregnant.
• Toremifene (5-10 mM) results in elevated levels of TRPM-2 and TGF beta 1 mRNAs in in vitro or in vivo grown tumor cells.

Maple Leaf Medications has provided information from third parties intended to increase awareness and does not contain all the information about Fareston (Toremifene Citrate). Talk to your doctor or a qualified medical practitioner for medical attention, advice, or if you have any concerns about Fareston (Toremifene Citrate). A prescription must be provided for Fareston as with all prescriptionmedicine here at MapleLeafMeds.com; there are no exceptions.

Toremifene is used to treat breast cancer that has spread to other parts of the body in women who have experienced menopause (‘change of life’; end of monthly menstrual periods). Toremifene is in a class of medications called nonsteroidal antiestrogens. It works by blocking the activity of estrogen (a female hormone) in the breast.

Toremifene Prices, Coupons, Copay Cards & Patient Assistance

However, with Fareston use, while no reduction occurs the circulating estrogen doesn’t have the ability to perform and feed breast cancer or the condition known as gynecomastia common to many steroid users. Toremifene Citrate (Fareston) is an anti-estrogenic medication, a SERM officially classified as a non-steroidal triphenylethylene derivative. As an anti-estrogen, Fareston functions by binding or attaching to the estrogen receptors in various tissues throughout the body creating a competition between it and the estrogen hormone. By attaching to the varying receptors this prevents the estrogen hormone from binding and performing its intended action. Primarily this will be beneficial in that it prevents the estrogen hormone from binding to the estrogen receptors in the mammary tissue. Toremifene-d6 Citrate is a deuterated form of Toremifene, used extensively in pharmaceutical research.

8 Women of Childbearing Potential

There are no adequate and well-controlled studies in pregnant women using toremifene citrate tablets. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus see Use in Specific Populations (8.1). Toremifene (5-10 mM) results in elevated levels of TRPM-2 and TGF beta 1 mRNAs in in vitro or in vivo grown tumor cells. Toremifene increases the incidence of hypernephromas in previously DEN-initiated rats. Vertigo, headache, steroids and dizziness were observed in healthy volunteer studies at a daily dose of 680 mg for 5 days. The symptoms occurred in two of the five subjects during the third day of the treatment and disappeared within 2 days of discontinuation of the drug.